Lam Research Corporation Reports Financial Results for the Quarter Ended June 26, 2022
Lam Research reported strong financial results for the quarter ending June 26, 2022, with revenue reaching $4.64 billion, a 14% increase from the previous quarter. U.S. GAAP diluted EPS climbed to $8.74, marking a 20% rise. The company achieved a gross margin of 45.3% and operating income of 31.9% of revenue. Looking ahead, Lam expects revenue between $4.9 billion +/- $300 million for the next quarter, maintaining a robust operational outlook despite a supply-constrained environment.
- Revenue of $4.64 billion, up 14% Q/Q.
- Diluted EPS increased to $8.74, up 20% Q/Q.
- Gross margin improved to 45.3%, a 60 bps increase Q/Q.
- Operating income as a percentage of revenue rose to 31.9%, up 250 bps Q/Q.
- Strong guidance with projected revenue of $4.9 billion +/- $300 million for next quarter.
- Cash and cash equivalents decreased to $3.9 billion from $4.6 billion.
- Operating expenses rose to $621 million, an increase from $625 million in the previous quarter.
FREMONT, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 26, 2022 (the “June 2022 quarter”).
Highlights for the June 2022 quarter were as follows:
- Revenue of
$4.64 billion . - U.S. GAAP gross margin of
45.3% , U.S. GAAP operating income as a percentage of revenue of31.9% , and U.S. GAAP diluted EPS of$8.74 . - Non-GAAP gross margin of
45.2% , non-GAAP operating income as a percentage of revenue of31.5% , and non-GAAP diluted EPS of$8.83 .
Key Financial Data for the Quarters Ended
June 26, 2022 and March 27, 2022
(in thousands, except per-share data, percentages, and basis points)
U.S. GAAP | |||||||||||
June 2022 | March 2022 | Change Q/Q | |||||||||
Revenue | $ | 4,635,554 | $ | 4,060,416 | +14 | % | |||||
Gross margin as percentage of revenue | 45.3 | % | 44.7 | % | + 60 bps | ||||||
Operating income as percentage of revenue | 31.9 | % | 29.4 | % | + 250 bps | ||||||
Diluted EPS | $ | 8.74 | $ | 7.30 | +20 | % | |||||
Non-GAAP | |||||||||||
June 2022 | March 2022 | Change Q/Q | |||||||||
Revenue | $ | 4,635,554 | $ | 4,060,416 | +14 | % | |||||
Gross margin as percentage of revenue | 45.2 | % | 44.7 | % | + 50 bps | ||||||
Operating income as percentage of revenue | 31.5 | % | 29.4 | % | + 210 bps | ||||||
Diluted EPS | $ | 8.83 | $ | 7.40 | +19 | % |
U.S. GAAP Financial Results
For the June 2022 quarter, revenue was
Non-GAAP Financial Results
For the June 2022 quarter, non-GAAP gross margin was
“Lam delivered record levels of revenue and earnings per share in the June quarter, while continuing to operate in a supply-constrained environment,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “With solid operational execution, technology leadership, and a robust installed base business, Lam is well-positioned for long-term growth.”
Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to
Deferred revenue at the end of the June 2022 quarter increased to
Revenue
The geographic distribution of revenue during the June 2022 quarter is shown in the following table:
Region | Revenue |
China | |
Korea | |
Taiwan | |
United States | |
Europe | |
Japan | |
Southeast Asia |
The following table presents revenue disaggregated between system and customer support-related revenue:
Three Months Ended | Twelve Months Ended | |||||||||||||
June 26, 2022 | March 27, 2022 | June 27, 2021 | June 26, 2022 | June 27, 2021 | ||||||||||
(In thousands) | ||||||||||||||
Systems revenue | $ | 3,006,374 | $ | 2,650,842 | $ | 2,763,877 | $ | 11,322,271 | $ | 9,764,845 | ||||
Customer support-related revenue and other | 1,629,180 | 1,409,574 | 1,381,302 | 5,904,768 | 4,861,305 | |||||||||
$ | 4,635,554 | $ | 4,060,416 | $ | 4,145,179 | $ | 17,227,039 | $ | 14,626,150 |
System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ended September 25, 2022, Lam is providing the following guidance:
U.S. GAAP | Reconciling Items | Non-GAAP | |||||||||
Revenue | +/- | — | +/- | ||||||||
Gross margin as a percentage of revenue | +/- | $ | 1 Million | +/- | |||||||
Operating income as a percentage of revenue | +/- | $ | 3 Million | +/- | |||||||
Net income per diluted share | +/- | $ | 3 Million | +/- | |||||||
Diluted share count | 137 Million | — | 137 Million |
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or realized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
- Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations,
$1 million . - Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations,
$3 million . - Net income per diluted share - amortization related to intangible assets acquired though business combinations,
$3 million ; amortization of note discounts,$1 million ; and associated tax benefit for non-GAAP items ($1 million ); totaling$3 million .
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the June 2022 and March 2022 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax benefit of non-GAAP items.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; our operational execution and technology leadership; the strength of our installed base business; and our prospects for growth. Some factors that may affect these forward-looking statements include: supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 27, 2021, and our quarterly reports on Form 10–Q for the fiscal quarters ended September 26, 2021, December 26, 2021 and March 27, 2022. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)
Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
Three Months Ended | Twelve Months Ended | ||||||||||||||||||
June 26, 2022 | March 27, 2022 | June 27, 2021 | June 26, 2022 | June 27, 2021 | |||||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | (1 | ) | ||||||||||||||
Revenue | $ | 4,635,554 | $ | 4,060,416 | $ | 4,145,179 | $ | 17,227,039 | $ | 14,626,150 | |||||||||
Cost of goods sold | 2,535,042 | 2,243,791 | 2,229,978 | 9,355,232 | 7,820,844 | ||||||||||||||
Gross margin | 2,100,512 | 1,816,625 | 1,915,201 | 7,871,807 | 6,805,306 | ||||||||||||||
Gross margin as a percent of revenue | 45.3 | % | 44.7 | % | 46.2 | % | 45.7 | % | 46.5 | % | |||||||||
Research and development | 411,157 | 407,120 | 381,749 | 1,604,248 | 1,493,408 | ||||||||||||||
Selling, general and administrative | 210,002 | 217,408 | 217,525 | 885,737 | 829,875 | ||||||||||||||
Total operating expenses | 621,159 | 624,528 | 599,274 | 2,489,985 | 2,323,283 | ||||||||||||||
Operating income | 1,479,353 | 1,192,097 | 1,315,927 | 5,381,822 | 4,482,023 | ||||||||||||||
Operating income as a percent of revenue | 31.9 | % | 29.4 | % | 31.7 | % | 31.2 | % | 30.6 | % | |||||||||
Other expense, net | (120,448 | ) | (57,402 | ) | (7,166 | ) | (188,708 | ) | (111,219 | ) | |||||||||
Income before income taxes | 1,358,905 | 1,134,695 | 1,308,761 | 5,193,114 | 4,370,804 | ||||||||||||||
Income tax expense | (149,971 | ) | (112,917 | ) | (164,104 | ) | (587,828 | ) | (462,346 | ) | |||||||||
Net income | $ | 1,208,934 | $ | 1,021,778 | $ | 1,144,657 | $ | 4,605,286 | $ | 3,908,458 | |||||||||
Net income per share: | |||||||||||||||||||
Basic | $ | 8.76 | $ | 7.34 | $ | 8.02 | $ | 32.92 | $ | 27.22 | |||||||||
Diluted | $ | 8.74 | $ | 7.30 | $ | 7.98 | $ | 32.75 | $ | 26.90 | |||||||||
Number of shares used in per share calculations: | |||||||||||||||||||
Basic | 137,993 | 139,229 | 142,662 | 139,899 | 143,609 | ||||||||||||||
Diluted | 138,313 | 140,057 | 143,514 | 140,628 | 145,320 | ||||||||||||||
Cash dividend declared per common share | $ | 1.50 | $ | 1.50 | $ | 1.30 | $ | 6.00 | $ | 5.20 |
(1) Derived from audited financial statements.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
June 26, 2022 | March 27, 2022 | June 27, 2021 | |||||||
(unaudited) | (unaudited) | (1) | |||||||
ASSETS | |||||||||
Cash and cash equivalents | $ | 3,522,001 | $ | 4,194,719 | $ | 4,418,263 | |||
Investments | 135,731 | 160,072 | 1,310,872 | ||||||
Accounts receivable, net | 4,313,818 | 3,702,320 | 3,026,430 | ||||||
Inventories | 3,966,294 | 3,479,332 | 2,689,294 | ||||||
Prepaid expenses and other current assets | 347,391 | 351,658 | 207,528 | ||||||
Total current assets | 12,285,235 | 11,888,101 | 11,652,387 | ||||||
Property and equipment, net | 1,647,587 | 1,561,875 | 1,303,479 | ||||||
Restricted cash and investments | 251,534 | 251,036 | 252,487 | ||||||
Goodwill and intangible assets | 1,616,963 | 1,627,035 | 1,622,499 | ||||||
Other assets | 1,394,313 | 1,260,984 | 1,061,300 | ||||||
Total assets | $ | 17,195,632 | $ | 16,589,031 | $ | 15,892,152 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||
Current portion of long-term debt and finance lease obligations | $ | 7,381 | $ | 7,689 | $ | 11,349 | |||
Other current liabilities | 4,557,378 | 4,187,052 | 3,516,518 | ||||||
Total current liabilities | 4,564,759 | 4,194,741 | 3,527,867 | ||||||
Long-term debt and finance lease obligations | 4,998,449 | 5,000,657 | 4,990,333 | ||||||
Income taxes payable | 931,117 | 916,668 | 948,037 | ||||||
Other long-term liabilities | 422,941 | 450,475 | 398,727 | ||||||
Total liabilities | 10,917,266 | 10,562,541 | 9,864,964 | ||||||
Stockholders’ equity (2) | 6,278,366 | 6,026,490 | 6,027,188 | ||||||
Total liabilities and stockholders’ equity | $ | 17,195,632 | $ | 16,589,031 | $ | 15,892,152 |
(1) Derived from audited financial statements.
(2) Common shares issued and outstanding were 136,975 as of June 26, 2022, 138,707 as of March 27, 2022, and 142,501 as of June 27, 2021
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Three Months Ended | Twelve Months Ended | ||||||||||||||||||
June 26, 2022 | March 27, 2022 | June 27, 2021 | June 26, 2022 | June 27, 2021 | |||||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | (1) | |||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
Net income | $ | 1,208,934 | $ | 1,021,778 | $ | 1,144,657 | $ | 4,605,286 | $ | 3,908,458 | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||
Depreciation and amortization | 87,932 | 84,228 | 78,397 | 333,739 | 307,151 | ||||||||||||||
Deferred income taxes | (173,987 | ) | (56,878 | ) | (146,029 | ) | (257,438 | ) | (151,477 | ) | |||||||||
Equity-based compensation expense | 69,588 | 68,543 | 56,321 | 259,064 | 220,164 | ||||||||||||||
Other, net | 33,574 | (3,121 | ) | (27,786 | ) | (44,751 | ) | (17,392 | ) | ||||||||||
Changes in operating assets and liabilities | (782,107 | ) | (356,840 | ) | 330,375 | (1,796,226 | ) | (678,741 | ) | ||||||||||
Net cash provided by operating activities | 443,934 | 757,710 | 1,435,935 | 3,099,674 | 3,588,163 | ||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||||
Capital expenditures and intangible assets | (125,746 | ) | (145,368 | ) | (104,622 | ) | (546,034 | ) | (349,096 | ) | |||||||||
Net sale of available-for-sale securities | 23,486 | 79,184 | 799,965 | 1,165,884 | 464,522 | ||||||||||||||
Other, net | 26,323 | (28,380 | ) | (6,282 | ) | (7,575 | ) | (42,155 | ) | ||||||||||
Net cash (used for) provided by investing activities | (75,937 | ) | (94,564 | ) | 689,061 | 612,275 | 73,271 | ||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||||
Principal payments on debt | (2,032 | ) | (1,821 | ) | (822,046 | ) | (11,889 | ) | (862,060 | ) | |||||||||
Treasury stock purchases | (876,089 | ) | (1,338,006 | ) | (431,255 | ) | (3,865,663 | ) | (2,697,704 | ) | |||||||||
Dividends paid | (208,056 | ) | (210,587 | ) | (185,385 | ) | (815,290 | ) | (726,992 | ) | |||||||||
Reissuance of treasury stock related to employee stock purchase plan | 61,798 | — | 56,330 | 108,178 | 97,764 | ||||||||||||||
Proceeds from issuance of common stock | 997 | 492 | 851 | 5,682 | 24,123 | ||||||||||||||
Other, net | (152 | ) | 214 | (269 | ) | 45 | (2,113 | ) | |||||||||||
Net cash used for financing activities | (1,023,534 | ) | (1,549,708 | ) | (1,381,774 | ) | (4,578,937 | ) | (4,166,982 | ) | |||||||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (16,683 | ) | (5,090 | ) | 702 | (30,227 | ) | 7,215 | |||||||||||
Net (decrease) increase in cash, cash equivalents, and restricted cash | (672,220 | ) | (891,652 | ) | 743,924 | (897,215 | ) | (498,333 | ) | ||||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 4,445,755 | 5,337,407 | 3,926,826 | 4,670,750 | 5,169,083 | ||||||||||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 3,773,535 | $ | 4,445,755 | $ | 4,670,750 | $ | 3,773,535 | $ | 4,670,750 |
(1) Derived from audited financial statements.
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended | |||||||
June 26, 2022 | March 27, 2022 | ||||||
Revenue | $ | 4,635,554 | $ | 4,060,416 | |||
Gross margin | $ | 2,094,006 | $ | 1,814,910 | |||
Gross margin as percentage of revenue | 45.2 | % | 44.7 | % | |||
Operating expenses | $ | 634,631 | $ | 620,636 | |||
Operating income | $ | 1,459,375 | $ | 1,194,274 | |||
Operating income as a percentage of revenue | 31.5 | % | 29.4 | % | |||
Net income | $ | 1,221,257 | $ | 1,036,359 | |||
Net income per diluted share | $ | 8.83 | $ | 7.40 | |||
Shares used in per share calculation - diluted | 138,313 | 140,057 |
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Three Months Ended | |||||||
June 26, 2022 | March 27, 2022 | ||||||
U.S. GAAP net income | $ | 1,208,934 | $ | 1,021,778 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold | 1,308 | 1,153 | |||||
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold | (7,814 | ) | (2,868 | ) | |||
EDC related liability valuation increase - research and development | (14,065 | ) | (5,161 | ) | |||
Amortization related to intangible assets acquired through certain business combinations -selling, general and administrative | 9,969 | 12,494 | |||||
EDC related liability valuation increase - selling, general and administrative | (9,376 | ) | (3,441 | ) | |||
Amortization of note discounts - other expense, net | 701 | 695 | |||||
Loss on EDC related asset - other expense, net | 32,316 | 13,118 | |||||
Net income tax benefit on non-GAAP items | (716 | ) | (1,409 | ) | |||
Non-GAAP net income | $ | 1,221,257 | $ | 1,036,359 | |||
Non-GAAP net income per diluted share | $ | 8.83 | $ | 7.40 | |||
U.S. GAAP net income per diluted share | $ | 8.74 | $ | 7.30 | |||
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation | 138,313 | 140,057 |
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)
Three Months Ended | |||||||
June 26, 2022 | March 27, 2022 | ||||||
U.S. GAAP gross margin | $ | 2,100,512 | $ | 1,816,625 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired through certain business combinations | 1,308 | 1,153 | |||||
EDC related liability valuation increase | (7,814 | ) | (2,868 | ) | |||
Non-GAAP gross margin | $ | 2,094,006 | $ | 1,814,910 | |||
U.S. GAAP gross margin as a percentage of revenue | 45.3 | % | 44.7 | % | |||
Non-GAAP gross margin as a percentage of revenue | 45.2 | % | 44.7 | % | |||
U.S. GAAP operating expenses | $ | 621,159 | $ | 624,528 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired through certain business combinations | (9,969 | ) | (12,494 | ) | |||
EDC related liability valuation increase | 23,441 | 8,602 | |||||
Non-GAAP operating expenses | $ | 634,631 | $ | 620,636 | |||
U.S. GAAP operating income | $ | 1,479,353 | $ | 1,192,097 | |||
Non-GAAP operating income | $ | 1,459,375 | $ | 1,194,274 | |||
U.S. GAAP operating income as percent of revenue | 31.9 | % | 29.4 | % | |||
Non-GAAP operating income as a percent of revenue | 31.5 | % | 29.4 | % |
Lam Research Corporation Contact:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com
FAQ
What were Lam Research's earnings results for June 2022?
How did Lam Research perform compared to the previous quarter?
What is the revenue guidance for Lam Research in the next quarter?